Showing results (81-90 of 146) with videos related to
Sort By:
Pageof 15
Journal of Nanobiotechnology|March 28, 2026
Overcoming lysosomal barrier via V-ATPase: an exosome-based co-delivery platform for combined chemo/RNAi therapy against breast cancerKeyao Liu, Tingting Xiong, Xueyuan Wang, et al.Epilepsy Research|May 17, 2026
The clinical utility of interictal multi-channel short-duration bursts: A supplemental biomarker for epileptogenic zone localizationHai Tang, Na Pan, Yicong Lin, et al.Aging|June 6, 2023
PZR promotes tumorigenicity of lung cancer cells by regulating cell migration and invasion via modulating oxidative stress and cell adhesionYing Fu, Yuan Sui, Yuming Zhao, et al.Journal of Materials Chemistry. B|April 19, 2022
Biomimetic multifunctional nanozymes enhanced radiosensitization for breast cancer via an X-ray triggered cascade reactionLin Yang, Xiao Du, Yanru Qin, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 24, 2026
Long-term efficacy of subthalamic nucleus deep brain stimulation in focal motor seizures and implications for candidate selectionBaoxin Xu, Xueyuan Wang, Xiaohua Zhang, et al.RSC Advances|May 6, 2022
Co-delivery of paclitaxel and gemcitabine via a self-assembling nanoparticle for targeted treatment of breast cancerMeng Lei, Sijia Sha, Xueyuan Wang, et al.Bioorganic & Medicinal Chemistry|June 24, 2018
Design, synthesis, in vitro and in vivo evaluation, and structure-activity relationship (SAR) discussion of novel dipeptidyl boronic acid proteasome inhibitors as orally available anti-cancer agents for the treatment of multiple myeloma and mechanism studiesMeng Lei, Huayun Feng, Enhe Bai, et al.Epilepsy Research|May 6, 2018
The surgical outcome of patients with bilateral temporal lobe epilepsyXiaoxia Zhou, Tao Yu, Guojun Zhang, et al.Brain Research Bulletin|August 4, 2020
The effect of vagal nerve stimulation on hippocampal-thalamic functional connectivity in epilepsy patientsJin Zhu, Cuiping Xu, Xi Zhang, et al.Journal of Medicinal Chemistry|November 7, 2024
Discovery of SZJK-0421: A Novel Potent, Low Toxicity, Selective Second Generation of CRM1 Inhibitor for the Treatment of Both Hematological and Solid TumorsHang Miao, Yanru Qin, DingLu Shao, et al.Pageof 15